UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 13(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

EXHIBIT 99.1 Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C. Saint-Herblain (France), March 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present on its single-shot chikungunya vaccine, IXCHIQ, moderate a roundtable on the Zika and chikungunya viruses, and participate in a panel discussion on efforts to eradicate chikungunya at the 24th World Vaccine C ...

Valneva SE (NASDAQ:VALN) Q4 2023 Results Conference Call March 20, 2024 10:00 AM ET Company Participants Joshua Drumm - Vice President of Investor Relations Thomas Lingelbach - President, CEO & Director Peter Buhler - Chief Financial Officer Conference Call Participants Max Herrmann - Stifel Maury Raycroft - Jefferies Evan Wang - Guggenheim Securities Ed White - H.C. Wainwright Nick Hallatt - Goldman Sachs Samir Devani - Rx Securities Joshua Drumm Thank you. Hello, and thank you for joining us to discuss Va ...

Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Conference Call November 9, 2023 9:00 AM ET Company Participants Joshua Drumm - VP, IR Thomas Lingelbach - Chairman, President & CEO Peter Buhler - CFO Conference Call Participants Maurice Raycroft - Jefferies Edward White - H.C. Wainwright & Co. Boran Wang - Guggenheim Securities Max Herrmann - Stifel, Nicolaus & Company Simon Scholes - First Berlin Samir Devani - Rx Securities Limited Operator Good day and thank you for standing by. Welcome to the Valneva 9 Months ...

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Conference Call September 21, 2023 9:00 AM ET Company Participants Joshua Drumm - VP, IR Thomas Lingelbach - CEO Peter Buhler - CFO Conference Call Participants Maury Raycroft - Jefferies Samir Devani - Rx Securities Simon Scholes - First Berlin Damien Choplain - Oddo BHF Evan Wang - Guggenheim Securities Suzanne Van Voorthuizen - VLK Max Herrmann - Stifel Operator Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call ...

Valneva SE (NASDAQ:VALN) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Joshua Drumm - VP, IR Thomas Lingelbach - Chairman, President & CEO Peter Buhler - CFO Conference Call Participants Kevin Strang - Jefferies Edward White - H.C. Wainwright & Co Boran Wang - Guggenheim Securities Simon Scholes - First Berlin Rajan Sharma - Goldman Sachs Group Samir Devani - Rx Securities Limited Max Herrmann - Stifel, Nicolaus & Company Operator Good day and thank you for standing by. Welcom ...

EXHIBIT 99.1 Valneva Reports Full Year 2022 Results and Provides Corporate Updates Total revenues of €361.3 million in 2022 compared to €348.1 million in 2021 Driven by product sales of €114.8 million (82.3% increase compared to 2021), including €85.2 million of travel vaccine sales and €29.6 million of COVID-19 vaccine sales €246.5 million of Other Revenues, primarily driven by revenue recognition related to previous COVID-19 vaccine supply agreements Strong cash position of €289.4 million at December 31, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 13(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

Valneva SE (NASDAQ:VALN) Q4 2022 Earnings Conference Call March 23, 2023 10:00 AM ET Company Participants Joshua Drumm - Vice President of Investor Relations Thomas Lingelbach - Chief Executive Officer Peter Buhler - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Evan Wang - Guggenheim Securities Max Herrmann - Stifel Nicolaus Rajan Sharma - Goldman Sachs Samir Devani - Rx Securities Operator 0Good day, and thank you for standing by. Welcome to the Valneva Full-Year 2022 Fin ...